Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences
New drugs and shorter treatments for drug-resistant tuberculosis (DR-TB) have become available in recent years and active pharmacovigilance (PV) is recommended by the World Health Organization (WHO) at least during the early phases of implementation, with active drug safety monitoring and management...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2019-10-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/28/153/180115.full |